uropro: Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT01766193
Collaborator
St. Olavs Hospital (Other)
1,641
1
18
91

Study Details

Study Description

Brief Summary

The lifetime risk for a woman to undergo surgery for either vaginal prolapse or urinary incontinence is high. Previous studies have shown that pregnancy and childbirth are risk factors for developing prolapse. There is a lack of studies that follow women several years after delivery aiming to find whether symptoms of prolapse are linked to delivery method, ie vacuum, forceps, normal vaginal delivery and cesarean section. The investigators plan this study is to get more knowledge about pathology of prolapse and incontinence, to enable development of preventive strategies for these conditions.

Aim of the study is to determine whether the prevalence of symptoms and performed surgery for urogenital prolapse differs among women delivered by vacuum, forceps, normal vaginal delivery and cesarean section 15-20 years after their first delivery.

The investigators identify women that delivered their first child at St. Olavs Hospital, Trondheim, Norway between 1990-1997. Questionnaires will be sent to 2500 women (PFIQ-7, PFDI-20, PISQ-12), 600 of whom will get a clinical examination, where pelvic floor musculature is examined by palpation and 4D ultrasound, and a POP-Q quantification of prolapse performed.

Condition or Disease Intervention/Treatment Phase
  • Procedure: vaginal delivery
  • Procedure: forceps extraction
  • Procedure: vacuum extraction
  • Procedure: cesarean section

Study Design

Study Type:
Observational
Actual Enrollment :
1641 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later
Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Feb 1, 2014
Actual Study Completion Date :
Feb 1, 2014

Arms and Interventions

Arm Intervention/Treatment
vaginal birth

women whose first child was born by spontaneous vaginal delivery

Procedure: vaginal delivery

cesarean section

women whose first child was born by cesarean section

Procedure: cesarean section

forceps

women whose first child was born by forceps extraction

Procedure: forceps extraction
vaginal delivery by forceps extraction

vacuum

women whose first child was born by vacuum extraction

Procedure: vacuum extraction
vaginal delivery by vacuum extraction

Outcome Measures

Primary Outcome Measures

  1. symptoms of urogenital prolapse [15-20 years after first delivery]

  2. surgery for urogenital prolapse [15-20 years after first delivery]

Secondary Outcome Measures

  1. damage to pelvic floor musculature [15-20 years after first delivery]

  2. urinary incontinence [15-20 years after first delivery]

  3. anal incontinence [15-20 years after first delivery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • first delivery in time period 1990-1997

  • vaginal birth, spontaneous, forceps or vacuum extraction, or cesarean section

  • residency in Klæbu, Malvik, Melhus, Midtre Gauldal, Rissa, Selbu, Trondheim, Tydal, Åfjord at the time of first delivery

Exclusion Criteria:
  • stillbirth

  • breech birth

  • congenital Abnormalities

  • residency outside the 9 selected communities

  • forceps delivery following previous vacuum extraction delivery or spontaneous vaginal birth

  • vacuum extraction delivery following previous forceps delivery or spontaneous vaginal birth

  • Vaginal birth following previous cesarean section

Contacts and Locations

Locations

Site City State Country Postal Code
1 St Olavs Hospital Trondheim University Hospital Trondheim Norway

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • St. Olavs Hospital

Investigators

  • Study Director: Kjell Å Salvesen, prof MD, Norwegian University of Science and Technology
  • Study Director: Siv Mørkved, PhD prof, St. Olavs Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01766193
Other Study ID Numbers:
  • 2012/666
First Posted:
Jan 11, 2013
Last Update Posted:
Feb 17, 2017
Last Verified:
Feb 1, 2017

Study Results

No Results Posted as of Feb 17, 2017